Objective: To assess the effects of different mesh fixation suture materials on the risk of recurrence after Lichtenstein inguinal hernioplasty.
T HE LICHTENSTEIN INGUInal hernioplasty with "tension-free" mesh reinforcement has become the criterion standard in inguinal hernia repair worldwide. [1] [2] [3] In Sweden, the Lichtenstein inguinal hernioplasty technique accounted for twothirds of all groin hernioplasties in 2008. 4 The procedure is one of the most standardized operations in general surgery. One characteristic and well-defined element of the operation is the fixation of the mesh, which, according to the originators, should be executed with nonabsorbable (ie, permanent) monofilament sutures.
Recently, it has been suggested that by substituting the mesh-anchoring sutures entirely with absorbable ones, the surgeon may reduce the patient's risk of developing chronic postoperative pain. [5] [6] [7] [8] [9] Whether such a policy would affect the recurrence rate has, to our knowledge, not been thoroughly investigated.
Recurrence rates in modern hernia treatment depend on a wide range of risk factors unrelated to the mesh fixation. Design of a study to detect a probably small, but clinically relevant, difference in the risk for recurrence exclusively related to the mesh fixation material is thus a challenge. A randomized controlled trial may be both difficult and time-consuming to perform to answer this question.
The aim of this study was to investigate the relative risk (RR) for reoperation due to hernia recurrence in cases when the mesh is secured mainly with long-term or short-term absorbable sutures, as compared with standard nonabsorbable sutures. To examine this, we analyzed data pertaining to the reoperation rate of nearly all Lichtenstein inguinal hernioplasties per-formed in Sweden during an 8-year period prospectively and consecutively registered in the nationwide Swedish Hernia Registry (SHR). 10 
METHODS

DATA FROM THE SHR
The SHR has almost complete nationwide coverage of groin (inguinal and femoral) hernioplasties in adolescents and adults. For every patient, the registration protocol mandates a number of variables to be prospectively recorded, including details regarding surgical technique ( Table 1) . The large sample size acts to minimize the risk of random error, thus ensuring good precision, even in subanalyses.
In Sweden, patient information is registered under the stateassigned personal identity numbers unique for each citizen and used for all health care and other governmental concerns. 11 Thus, patients can be monitored annually to adjust data according to life tables for deaths and to link recurrent hernia repairs to any previous operations.
The SHR defines reoperation of recurrence as any kind of hernia repair in a groin in which a hernia had previously been repaired when the patient was 15 years or older. This definition applies even in the event that the primary and recurrent hernias are anatomically different, eg, if the first repair was for an inguinal hernia and the reoperation addressed a femoral defect. More information about the SHR, including its data recording and validation, is available in earlier publications 12, 13 and on Web sites. 4, 10 In 2002, the SHR introduced a new variable: the means by which hernia mesh is affixed ( Table 2 ). The study reported here was based on SHR data for the 8 years after that addition ( January 1, 2002-December 31, 2009). Inclusion criteria were Lichtenstein inguinal hernioplasty procedures in which the mesh was fastened mainly with nonabsorbable, long-term absorbable, or short-term absorbable sutures, which define the 3 study groups in this investigation.
This study was granted official approval status by the Research Ethics Committee of Stockholm University.
STATISTICS
To calculate the cumulative risk of recurrent surgery throughout the study, the primary endpoints for analysis were the date for reoperation of a hernia in the same groin or the date of death. Subsequently, the RRs for reoperation were computed for each of the 3 suture groups by Cox multiple regression analysis 14 to adjust for potential confounders (Table 1) . For the comparison, standard fixation was chosen as reference (RR, 1). An RR greater than 1 signified a larger risk for reoperation than for nonabsorbable sutures, whereas an RR less than 1 indicated a smaller risk. The statistics were calculated with R (opensource free software) version 2.7.2.
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RESULTS
During the study period, the SHR recorded 130 359 mesh and nonmesh repairs of groin hernias in adolescents and adults (aged 15 years or older), constituting more than 95% of all hernioplasties in Sweden. Of these, 82 015 met the inclusion criteria, (ie, Lichtenstein inguinal hernioplasty with mesh fixation by sutures) (Figure 1) .
In the majority of the procedures, the mesh was secured with standard nonabsorbable sutures (n=78 867). The 2 study groups with long-term absorbable (n=1938) and short-term absorbable (n=1210) mesh fixation sutures represent less common modifications ( Table 2 ).
The reoperation rates are listed in Table 3 and the cumulative risks are displayed in Figure 2 .
The RRs for reoperation are given in Table 4 . In comparison with permanent sutures (RR, 1), mesh fixation with short-term absorbable sutures more than doubled a patient's RR for reoperation (RR, 2.23). The reoperation rates for the nonabsorbable and long-term absorbable suture groups were similar.
COMMENT
This large, population-based study was designed to detect possible risk differences for the outcome of clinical interest (recurrence), depending on the type of mesh fixation suture material used for the Lichtenstein inguinal hernioplasty. For practical reasons, we used a surrogate end point (reoperation due to recurrence). Our data demonstrate that the use of short-term absorbable sutures more than doubled the reoperation risk, whereas long-term absorbable sutures manifested no significant risk.
The follow-up period ranged from 0 to 8 years. During the study period, the cumulative reoperation curves for all 3 study groups were fairly linear and constant. Whether this pattern will prevail is yet to be seen. There are 2 primary strengths of this study. First, the 3 study groups comprise almost all patients treated in Sweden with the procedure of interest during the study period. As the SHR has nationwide coverage and documents virtually every adolescent and adult inguinal and femoral hernia operation conducted in Sweden, it compiles an unselected and unbiased database.
Second, our findings are in line with results obtained from studies on abdominal wound closure, where shortterm absorbable sutures have been shown to constitute an independent risk factor for incisional hernia formation and long-term absorbable sutures do not. [16] [17] [18] [19] [20] In addition, research on nonmesh groin herniorrhaphy has demonstrated that short-term absorbable sutures raise the recurrence risk, whereas long-term absorbable sutures do not. [21] [22] [23] One may consider a weakness of our study to be uneven distribution of the 3 groups, with less than 4% of the procedures divided into the 2 absorbable suture groups (Figure 1 ). Notwithstanding these modest percentages, these groups collectively comprise 3148 repairs performed by several hundred surgeons. Therefore, we consider the risk that individual practices of attending surgeons will manifest as statistical outliers and skew the overall results to be minimal.
Given that this study was not a randomized controlled trial, it provides only a descriptive account of surgical outcomes documented for nearly the entire patient population of a single country. As such, it makes no attempt to control for or even declare the reasons underlying decisions to deviate from standard use of nonabsorbable suture fixation. Thus, biased patient selection is a possibility that might confound determination of the recurrence risk. However, multiregression analysis adjusts for essential disparities between study groups concerning other risk factors.
A strength of the Lichtenstein inguinal hernioplasty procedure, in contrast to other methods of hernia repair, is that it enables even nonexpert surgeons to repair groin hernias with few recurrences. 4, [24] [25] [26] [27] [28] In recent years, however, the issue of chronic postoperative pain has been addressed. Several authorities in the field of hernia surgery have argued that posthernioplasty pain should be a greater cause for concern than should recurrence rates. [29] [30] [31] Tissuepenetrating anchoring of mesh is recognized to be a plausible cause of chronic discomfort. [31] [32] [33] [34] [35] [36] Removal of the permanent fixation material can thus sometimes be an effective remedy. 5, 6, 8 Further studies regarding whether absorbable mesh fixation may reduce the incidence of persistent postoperative pain need to be performed. It is nevertheless important that measures with the intention to reduce the risk for chronic pain do not increase the recurrence risk.
When launched in 1992, the primary objective of the SHR was to assess variables associated with recurrence risk. Since then, the chronic postoperative pain issue has achieved increasingly more attention worldwide. As shown in Table 1 , the SHR has not routinely recorded data concerning chronic pain beyond 30 days. Therefore, we regret that the SHR at this time does not possess data suitable to assess causal relationships between mesh fixation and chronic pain. However, for some time, the SHR has made efforts to develop a new pain evaluation protocol that is simple enough to be accepted by Swedish surgeons for use in their daily practice and, at the same time, complex enough to be scientifically useful and valid. A pilot study with a test protocol is currently being conducted in a limited number of hospitals.
To our knowledge, there have been no previous studies investigating whether a shift from permanent to absorbable mesh fixation will increase the recurrence rate after a hernioplasty. We hypothesized that for some patients, the mesh fixation material will play a crucial role in the long-term outcome of their hernioplasty. Still, the abundance of other plausible recurrence risk factors, some of them potentially more influential than the choice of suture material, makes it difficult to determine which one was the principal factor for hernia recurrence in each case. Many might consider a randomized controlled trial to be the most appropriate study design to assess the importance of mesh fixation suture material; however, that would necessitate an enormous number of patients and several years of observation time, entailing an economically and logistically formidable, if not impossible, project. We chose, therefore, to conduct a registry study rather than a randomized controlled trial because recurrence constitutes a rare event, one furthermore influenced by many risk factors. We believe that a study based on data derived from a large nationwide registry has better prerequisites for costeffectiveness and valid statistical inference. 37 In a recent commentary in the Archives, 38 advantages of national registry studies were noted: very large patient samples increase study power and facilitate multivariate analysis, and the broad range of physicians involved in treatment strengthens the external validity (generalizability) of the results (ie, the outcome is likely to reflect what may be expected in routine practice).
Large numbers of cases, such as the 3 groups studied here, are sine qua non for adequate multiregression. There were very few less-frequent alternatives for mesh fixation (glue, staples/tacks, other/unspecified, or no fixation) in the SHR, and the number of reoperations was even smaller. Therefore, these rarities recorded in the SHR may not yet be considered adequate for appropriate statistical inference regarding reoperation risk.
The exact date of a recurrence is an unsuitable end point in hernia studies because it can only be arbitrarily defined and still rarely be pinpointed. Even in prospective trials, the diagnosis (of recurrence) is always made in retrospect. Therefore, the recurrence date is not recorded in the SHR or in hernia studies. Instead, since the SHR registers both the primary and recurrence operation dates, we selected the day of reoperation as the primary end point. This enabled precise calculation of the reoperation rate, which we consider an adequate surrogate factor for recurrence rate.
From the patient's perspective, a recurrent hernia evolves in the following manner: anatomic recurrence, clinical manifestation, diagnosis, and potential reoperation. This evolution varies per individual and may span from hours to decades. This might be one of several plausible explanations for the observation in Figure 2 that the reoperation curves continue to separate long after one would expect the absorbable sutures to be gone. Furthermore, reoperation is not performed on a significant number of recurrent hernias, which sometimes are not even diagnosed. Thus, the recurrence rate will always be higher than the reoperation rate. At any given time, the true rate of clinically detectable recurrences can be estimated to be approximately 3 times higher than the SHR reoperation rate. 39 The delay from recurrence to reoperation is most likely dependent on factors similar for all 3 study groups. When comparing the alternative fixation materials, it is therefore reasonable to assume the calculated RR for a reoperation to be approximately the same as the true RR for a recurrence (in this case, as compared with standard nonabsorbable sutures).
CONCLUSIONS
In most cases, all 3 types of suture material worked well for the mesh fixation after the limited follow-up time. Still, (REPRINTED) for some patients, short-term absorbable sutures seemed to constitute an independent cause of failure. At this time, we have no clinical method to detect preoperatively the group of patients for whom the choice of fixation material may make a difference. Furthermore, so far there is no scientific evidence to recommend short-term absorbable sutures to alleviate the risk for chronic postoperative pain.
To minimize hernia recurrence following the Lichtenstein inguinal hernioplasty, we recommend either nonabsorbable or long-term absorbable sutures for the mesh fixation in all cases and advise against short-term absorbable sutures. 
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INVITED CRITIQUE
Surgical Registries
Effective, but How to Pay for Them? R egistries such as the nationwide SHR are powerful tools to evaluate adoption of practices and their effectiveness. Surgical registries are of particular importance as technical aspects and patient factors can be analyzed together to determine the effectiveness of an operation. Novik et al reported that during an 8-year study period, 1.5% of Lichtenstein inguinal hernias had mesh fixation with short-term absorbable suture. Although there was no significant increase of that practice during the observation period, mesh fixation with short-term absorbable suture had a greater than 2-fold hazard of reoperation due to hernia recurrence. Mesh fixation methods have been implicated as a potential cause of chronic groin pain following inguinal hernioplasty. In trying to improve outcomes for patients, surgeons adopted an unexpectedly less effective practice. Without a nationwide registry, this finding may have taken much longer to become apparent.
For registries to be effective, they must contain complete and accurate data and mechanisms for systematic follow-up and audits of the data. The barriers for implementing surgical registries in the United States are obvious: consensus about what to measure; who will be responsible for collecting, entering, and auditing the data; and how follow-up information will be collected. The costs and barriers are minor in comparison with costs associated with randomized controlled trials. Furthermore, registries serve as natural experiments. Surgeons are innovative and adopt new techniques or products, often without the necessary evidence to support effectiveness or potential harm. Registries provide a rational collective experience of innovation and allow for critical, objective assessments. Some treatments will need evaluation via clinical trials, but registries can direct areas of further study, as well as provide a broader patient population to determine effectiveness. Surgical societies, thirdparty payers, and industry need to come together to fund these endeavors. 
